Corrigendum to “60P Hepatic arterial infusion chemotherapy and bevacizumab in combination with toripalimab for advanced biliary tract cancers: A phase II trial” [Annals of Oncology 33 (2023) S568]
Titel:
Corrigendum to “60P Hepatic arterial infusion chemotherapy and bevacizumab in combination with toripalimab for advanced biliary tract cancers: A phase II trial” [Annals of Oncology 33 (2023) S568]
Auteur:
Wang, X. Fu, S. Zheng, K. Cao, G. Xu, L. Yang, R. Zhu, X. Liu, P. Gao, S. Xu, H. Guo, J. Chen, H. Wang, K. Li, J. Zhou, J. Zhang, X. Hao, C. Xing, B. Shen, L.